Novartis India is 76% subsidiary of Swiss drug major Novartis AG.Company's Indian operations can be classified into Pharmaceuticals, Generics, OTC and Animal Health.Novaris have some good brands like Voveran,Otrivin ..etc Company also own some popular brands like Sandimmun, Neoral,Tegrital.
In the animal health division company's brands include Natuzyme,Denagard..etc.
In 2009 ,company came out with an open offer and raised the parent's stake to current level.
In recent times company showing aggressiveness in development and marketing of new products especially in
Cough, Cold, and Allergy category. Reflection of the same is already visible in its financials.
For the latest December quarter company posted a turnover of Rs.184 Cr ( Rs.160 Cr) and a net profit of RS.41 Cr (Rs.23 Cr) Full year EPS is expected around Rs.48/-.Along with good prospects of pharma industry in India due to increasing health awareness and government focus,company's better commitment after hiking its parent's stake is expected to augurs well for Novartis going forward.At CMP of Rs.622,Novartis is a good bet from pharma sector.
hi sir i wanted to get valuable advise abt spicejet ,after hikes in fuel price do u think its a hold even though it is an only profit making listed company in aviation space for long term.
ReplyDeleteDue to the recent allegations about the promoter group and rising trend of ATF ,near future seems to be difficult for the company.
ReplyDeleteJSW Energy quoting around Rs.75.Is it a safe bet now?
ReplyDeleteRegards,
Joshy
sir can you throw some light on MIC electronics, PRAJ, VULCAN, OK PLAY and UNI ABEX alloys?
ReplyDeletethanks in advance and sorry for asking about too many scrips.
regards
senthil
hello value pick
ReplyDeletei have bought 5000 shares ludlow at avg price of 70 on ur recommendation. cmp= 53 what is ur view ???
JSW is good for long term
ReplyDeleteDear Sentil
ReplyDeleteI am tracking only Vulcan Engineering.Result of change in management is expected in future.Investors with sufficient patience may consider Vulcan for long term
Dear narendra
ReplyDeleteDue to a rise in raw material cost and a fire in company godown in October affected its performance. It is expected to perform well going forward.Better to wait for some more time.
Hi valuepick,
ReplyDeleteI am reading some of the warren buffett books. He disagrees with the concept of portfolio diversification across multiple sectors. He says that if you have selected 20 good company's, out of them why to put your money in to your 20th choice, rather than putting in to your top 5 or 10?
whats your opinion on this. does this will be applicable to our Indian markets ?
Thanks
Sravani
thank u value pick on ur views ON ludlow JUTE..
ReplyDeletethank you valuepick for your opinion on JSW
ReplyDeleteDear srav
ReplyDeleteNo doubt about it .Over diversification needs only when we have no conviction and confidence on a company.
thanks a lot for your feedback sir. Do you suggest any good books to read on stock market analysis ? please help me in this.
ReplyDeleteThanks
Sravani
Dear Valuepick,
ReplyDeleteI too hold ludlow.
Price of jute has gone up a lot and bangladesh is not exporting jute. Considering supply side constraints price of jute is expected to remain high. Wont this affect ludlow's profitability and margins in a big way? How do you think performance will improve going forward?
-dilip
Dear Dilip
ReplyDeleteWhat you said is right .But I feels many of the negatives are already reflecting in its stock price. There may be some margin pressure in short term .Expecting mandatory shift from plastic to jute in various fields in near future which will help the companies to pass the additional burden to consuming companies .
Dear Dilip
ReplyDeleteWhat you said is right .But I feels many of the negatives are already reflecting in its stock price. Expecting a shift from plastic to jute in various fields going forward. Such a mandatory change will help the companies to rise the price and keep margins. Short term margin pressure may happen.
Dear Valuepick,
ReplyDeleteThanks for your views.
I agree that a lot of negatives have been factored in the current price. I have ludlow at around 80rs. I was thinking of averaging. On one hand, after seeing Dec quarter EPS, I feel it might correct more even from current market price in terms of PE multiple. But on the other hand, its market cap is below 50crore and I am wondering if thats already cheap.
-dilip